Desloratadine/dihydroartemisinin/piperaquine (DL/D/P) showed promising
therapeutic activity on Plasmodium berghei. This study evaluated its renal
impact on healthy and Plasmodium berghei-infected mice. Fifty-four adult Swiss
albino mice used were randomized into 9 groups. Thirty mice (n=6/group)
were inoculated with Plasmodium berghei (1 X 107
) and treated with normal
saline (0.2ml) (Parasitized control), DL, D/P and DL/D/P daily for 4 days,
respectively. The non-parasitized control was treated with normal saline
(0.2ml) daily for 4 days. In the sub-acute toxicity study, twenty four healthy
mice (n=6) were treated with normal saline (0.2ml) (Control), DL, D/P and
DL/D/P daily for 28 days, respectively. After treatment, the mice were
weighed and anesthetized. Blood samples were collected and evaluate for
renal biochemical markers. Kidney samples were weighed and analysed for
markers of oxidative stress and histology. DL, D/P and DL/D/P did not
produce significant (p>0.05) effects on renal function markers in parasitized
mice when compared to control. DL, D/P and DL/D/P significantly decreased
body weight and significantly increased kidney weight in healthy mice at
p<0.05, p<0.05 and p<0.01, respectively when compared to control. Serum
creatinine, urea, uric acid and kidney malondialdehyde levels were increased
significantly in DL (p<0.05), D/P (p<0.05) and DL/D/P (p<0.01) treated healthy
mice when compared to control. Significantly decreased kidney glutathione
peroxidase, superoxide dismutase, glutathione, and catalase levels were
observed in healthy mice treated with DL (p<0.05), D/P (p<0.01) and DL/D/P
(p<0.001) when compared to control. DL/D/P produced tubular necrosis,
vacuolated glomerular mesangial cells and increased Bowman’s space in
healthy mice. The prolonged use of DL/D/P may cause renal dysfunction
Keywords: Dihydroartemisinin/piperaquine, Desloratadine, Plasmodium,
Mice, Renal, Toxicity